Blood clots are more likely to arise from other causes, according to Business Minister Paul Scully. Appearing on Good Morning Britain he said people are more likely to get clots from aspirin than the Covid jab. Scully’s reassuring note comes after a recent trial of the vaccine in around 300 children was paused while the UK medicines regulatory investigates the possibility of links to a rare blood clotting syndrome in adults.
But a University of Oxford spokesperson has stressed there are “no safety concerns” with the study, but further information is being awaited from the Medicines and Healthcare products Regulatory Agency (MHRA).
A number of countries suspended use of the Oxford-AstraZeneca vaccine after the first reports of blood clots.
At the end of March, Germany pended routine use of the vaccine for people aged below 60 because of a risk of rare blood clots.
The German medicines regulator found 31 cases of a type of rare blood clot among the nearly 2.7 million people who had received the vaccine in Germany.
READ MORE: High cholesterol symptoms: Three serious warning signs in your feet – what to look for
Asked whether there’s a possibility this could happen here in the UK, Scully answered: “[There’s] no suggestion that is even the case, here in the UK.
“The MHRA have been really clear you’re more likely to have side effects from taking aspirin than you are with this.
“It’s 0.0000016 of a percent that there are people having clots, and that’s not necessarily a causation between the two.”
The UK government has released information on possible side effects of the AstraZeneca vaccine.
It states: “Like all medicines, this vaccine can cause side effects, although not everybody gets them. In clinical studies with the vaccine, most side effects were mild to moderate in nature and resolved within a few days with some still present a week after vaccination.
“If side effects such as pain and/or fever are troublesome, medicines containing paracetamol can be taken.”
“Very common” side effects that have occurred during clinical trials include:
- tenderness, pain, warmth, itching or bruising where the injection is given
- generally feeling unwell
- feeling tired (fatigue)
- chills or feeling feverish
- feeling sick (nausea)
- joint pain or muscle ache
Over the weekend it was reported there had been 30 blood blotting cases recorded by the MHRA out for more than 18 million doses of the AstraZeneca vaccine administered.
The MHRA confirmed of those 30 people, seven had died, as of 24 March.
The European Medicines Agency’s head of vaccine strategy has said it is “increasingly difficult” to say there is “no cause and effect relationship” between the AstraZeneca jab and blood clots.
The World Health Organisation is expects to report findings from an assessment this week, but has so far maintained the benefits of the vaccine outweigh any risks.